Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Jay Epstein; Martin Smid; Silvano Wendel; Daniel Somuah; Thierry Burnouf

doi:10.1038/s41541-020-00256-6

Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Jay Epstein, Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

30 Downloads (Pure)

Abstract

Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in
low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized
quality standards should collect CCP.

Original language	English
Article number	103
Number of pages	2
Journal	npj Vaccines
Issue number	1
DOIs	https://doi.org/10.1038/s41541-020-00256-6
Publication status	Published - 1-Dec-2020
Externally published	Yes

Access to Document

10.1038/s41541-020-00256-6Licence: CC BY

Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infectionsFinal publisher's version, 531 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{aa0f6d870b0a4c9eba7f4d6ba620ccb2,

title = "Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.",

abstract = "Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research inlow- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognizedquality standards should collect CCP.",

author = "Jay Epstein and Martin Smid and Silvano Wendel and Daniel Somuah and Thierry Burnouf",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41541-020-00256-6",

language = "English",

journal = "npj Vaccines",

issn = "2059-0105",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

AU - Epstein, Jay

AU - Smid, Martin

AU - Wendel, Silvano

AU - Somuah, Daniel

AU - Burnouf, Thierry

PY - 2020/12/1

Y1 - 2020/12/1

N2 - Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research inlow- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognizedquality standards should collect CCP.

AB - Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research inlow- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognizedquality standards should collect CCP.

U2 - 10.1038/s41541-020-00256-6

DO - 10.1038/s41541-020-00256-6

M3 - Article

SN - 2059-0105

JO - npj Vaccines

JF - npj Vaccines

IS - 1

M1 - 103

ER -

Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Abstract

Access to Document

Handle.net

Fingerprint

Cite this